New York, New York, United States In 1997 was created Senvest Management, which is appeared as VC. The company was established in North America in United States. The main department of described VC is located in the New York.
Among the most successful fund investment fields, there are Pharmaceutical, Biopharma. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Pharmacopeia.
Deals in the range of 5 - 10 millions dollars are the general things for fund. The high activity for fund was in 2005. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2008.
The standard case for the fund is to invest in rounds with 10 partakers. The meaningful sponsors for the fund in investment in the same round are Nite Capital Management, Iroquois Capital, Highbridge Capital Management.
Related Funds
| Fund Name | Location |
| Central Piedmont Investment Group | - |
| Entrenext Ventures | Florida, United States, Winter Park |
| HAT Sicaf SpA | Italy, Lombardia, Milano |
| Innovation Bridge | Boston, Massachusetts, United States |
| New York University | New York, New York, United States |
| Pivotal Capital | California, Menlo Park, United States |
| Sallfort Privatbank AG | Basel, Basel-Stadt, Switzerland |
| Scion Capital | - |
| Searchbox | Geneva, Geneve, Switzerland |
| Shri Investments | - |
| SooChow Securities | China, Jiangsu, Suzhou |
| Stakeboat Capital | Bengaluru, India, Karnataka |
| The Baupost Group | Boston, Massachusetts, United States |
| TMCT Ventures | California, Santa Monica, United States |
| Wolfswood Partners | New York, New York, United States |
| Wonderplanet | Japan, Kyūshū, Nishiki |
| Wuhu Qichen Investment Management | Anhui, China, Wuhu |
| Z80 Labs Technology Incubator | Buffalo, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Tasso | $100M | 16 Dec 2021 | Seattle, Washington, United States | ||
Biolinq | $100M | 02 Nov 2021 | San Diego, California, United States | ||
AIStorm | $16M | 15 Dec 2020 | San Jose, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Tasso | $100M | 16 Dec 2021 | Seattle, Washington, United States | ||
Biolinq | $100M | 02 Nov 2021 | San Diego, California, United States | ||
AIStorm | $16M | 15 Dec 2020 | San Jose, California, United States |
